key: cord-0934608-c4b7sf6x
authors: Biji, Abhijith; Khatun, Oyahida; Swaraj, Shachee; Narayan, Rohan; Rajmani, Raju; Sardar, Rahila; Satish, Deepshikha; Mehta, Simran; Bindhu, Hima; Jeevan, Madhumol; Saini, Deepak K; Singh, Amit; Gupta, Dinesh; Tripathi, Shashank
title: Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples
date: 2021-04-12
journal: bioRxiv
DOI: 10.1101/2021.02.18.431825
sha: f18f3c80e3278cdc936fcdf573f16e713dfa682e
doc_id: 934608
cord_uid: c4b7sf6x

While our battle with the COVID-19 pandemic continues, a multitude of Omics data has been generated from patient samples in various studies, which remains to be translated. We conducted a meta-analysis of published transcriptome and proteome profiles of nasal swab and bronchioalveolar lavage fluid (BALF) samples of COVID-19 patients, to shortlist high confidence upregulated host factors. Subsequently, mRNA overexpression of selected genes was validated in nasal swab/BALF samples from a cohort of COVID-19 positive/negative, symptomatic/asymptomatic individuals. Analysis of these data revealed S100 family genes (S100A6, S100A8, S100A9, and S100P) as prognostic markers of COVID-19 disease. Furthermore, Thioredoxin gene (TXN) was identified as a significant upregulated host factor in our overlap analysis. An FDA-approved drug Auranofin, which inhibits Thioredoxin reduction, was found to mitigate SARS-CoV-2 replication in vitro and in vivo in the hamster challenge model. Overall, this study translates COVID-19 host response Big Data into potential clinical interventions.

The COVID-19 pandemic has emerged as the biggest global public health crisis of this 37 century. As of April 11, 2021, more than 136 million infections and 2.9 million 38 casualties have been reported (https://www.worldometers.info/coronavirus/). The 39 causative agent SARS-CoV-2 contains a single-stranded positive-sense RNA genome 40 that encodes ~27 proteins (1). COVID-19 disease is quite heterogeneous, and its 41 manifestation ranges from asymptomatic, mild, severe to lethal, depending on a 42 variety of host, virus, and environmental factors (2) . Age, sex, ethnicity, and co-43 morbidities, all have been implicated in determining disease outcome (2) (3) (4) ). An 44 effective and timely interferon (IFN) response is critical in resolving viral infections (3), 45 however, SARS-CoV-2 has multiple strategies to suppress host immune response (4). 46 Disruption of immune homeostasis and induction of cytokine storm has been 47 recognized as one of the underlying causes of severe , yet the molecular 48 mechanisms underlying immune dysregulation are yet to be defined. The goal of our study was to identify genes that are consistently upregulated during 67 SARS-CoV-2 infection in the upper respiratory tract of patients and understand their 68 role in viral infection and disease progression. For this, we surveyed the literature for 69 Omics data from COVID-19 positive patient's nasal swab and BALF samples and 70 selected 4 transcriptomic and 3 proteomic datasets. We performed a hypergeometric 71 distribution-based overlap analysis followed by cumulative fold change score-based 72 prioritization to shortlist genes. This was followed by an examination of selected gene 73 expression levels in nasal swab/ BALF samples from a cohort of COVID positive, 74 negative, symptomatic, and asymptomatic individuals, ranging from 30-60 years in age 75 and of mixed gender. ROC analysis of gene expression data in nasal swabs revealed 76 S100 family genes (S100A6, S100A8, S100A9, S100P) as high confidence markers 77 of disease severity. Among other shortlisted genes, Thioredoxin (TXN) emerged as a 78 significantly upregulated factor supported by multiple datasets. Thioredoxin is a 79 proinflammatory protein that requires to be reduced by Thioredoxin reductase enzyme, 80 which itself can be targeted by an FDA-approved gold drug Auranofin (17, 18) . We 

Compilation and overlap analysis of published transcriptomics and proteomics 101 data from COVID-19 patient samples revealed 567 upregulated host factors. 102 We started the study by compiling the host factors that are consistently and 103 significantly upregulated in the upper respiratory tract of COVID-19 patients. For this, 104 we decided to use published transcriptomics and proteomics datasets derived from 105 nasal swab or BALF samples of COVID-19 patients. We chose four transcriptomics 106 (T), and three proteomics (P) datasets and further analysis was performed according 107 to a rationally designed workflow ( Figure 1A ). All datasets included differentially 108 expressed genes in infected patients with healthy individuals as control (Table S1 ).

The selection criteria (described in materials and methods) included at least 1.5-fold 110 (2-fold for one dataset) gene upregulation at both mRNA and protein levels. The 111 filtration of data was carried out to sort only significantly upregulated genes from all 112 the datasets (Table S2) . A pairwise overlap analysis was performed on the filtered 113 genes/proteins from each study and significantly overlapping genes (p-value < 0.01 114 calculated using Fisher's exact test) between T1-T3 (14), T1-T4 (9), T1-P3 (2) For validation using qRT-PCR and further analysis, we selected genes with a 186 cumulative score greater than 10 ( Figure 2C ). Also, we considered genes belonging 187 to the S100 family that came up within 46 shortlisted genes, since they are known 188 regulators of inflammation (27, 28) . Furthermore, we also selected the TXN since it Multiple genes from the S100 family, including S100A8, S100A9, S100A6, and S100P, and S5). The qRT-PCR data revealed that all the selected genes were induced in 220 positive symptomatic patients, irrespective of age or gender. However, closer 221 examination of the heatmap reveals S100 family genes (S100A8, S100A9, S100P) Figure 4B ). The optimal Ct value cut-off was determined for significant 239 genes using the ROC01 method which finds the point in the ROC curve closest to (0,1) 240 corresponding to 100% specificity and sensitivity. Since the prognostic marker should 241 correctly identify symptomatic patients from asymptomatic ones, we looked at the 242 genes with maximum sensitivity while not compromising on specificity at the optimal 243 cut-off. S100A8 (Cut-off = 9.964663, Sensitivity = 0.938, Specificity = 0.688) had the 244 highest sensitivity at the optimal cut-off. Other S100 family members like S100A9 (Cut- and bioavailability in rodents have been described before (33), based on which we first 278 tested its oral toxicity in hamsters at 1mg and 5mg/kg body weight, which showed the 279 drug was well tolerated at the tested doses ( Figure S7 ). For infection studies, the drug 280 was orally administered in prophylactic and therapeutic formats; before and after 281 infection respectively ( Figure 5D ). The viral titers in lungs of animals at Day 4 revealed 282 that therapeutic administration of Auranofin with a non-toxic concentration of 5mg/kg 283 body weight was more effective at mitigating virus replication (reduction by more than 284 one order of magnitude) in lung tissue, compared to prophylactic dosage ( Figure 5E ).

Bodyweight loss results were also indicative of the same when compared to the virus 286 challenge group ( Figure 5F ). Also, we found that the TXN gene was upregulated in the 287 lungs of infected animals compared to the mock group, which correlates to our findings infection and disease progression. We reasoned that changes at mRNA levels must 300 also be manifested at the protein level to bring out phenotypic differences in the 301 infected individuals. Hence, we designed our meta-analysis pipeline to shortlist genes 302 that were represented in orthogonal transcriptomics as well as proteomics datasets.

Expression of the genes selected through meta-analysis was examined in nasal 

Subsequent ranking of genes based on cumulative upregulation score across different 324 datasets, with dual support from transcriptomic and proteomic evidence, shortlisted 14 325 high confidence upregulated genes (Fig 2B) . To confirm their upregulation during 326 SARS-CoV-2 infection and the effect of patient age, sex, disease severity on the same, 327 their expression was measured in a cohort of patients described earlier (Table 1) . The 328 data revealed that 11 genes were upregulated significantly in the PS category when 329 compared to PA and hence had prognostic value. Whereas 8 genes were upregulated 330 when compared to the NS category, hence had diagnostic value ( Figure 3B ). The data 331 indicated higher levels of selected gene expression in younger male patients, which is 332 consistent with previous reports of age and sex-dependent differences in COVID-19 333 induced gene expression and disease severity (6, 40). Among host factors that 334 appeared at the end of meta-analysis and validation in the COVID-19 cohort, the S100 335 family of genes (S100A6, S100A8, S100A9, S100A12, S100P) emerged as a major 336 group. An upregulation of S100 proteins is reported previously as an indication of viral 337 or bacterial infections (27). The extracellularly secreted S100 proteins include 338 S100A12, S100A8, and S100A9 ( Figure S1A also reported which report an upregulation in S100A12, S100A8, S100A9, and S100P 347 in patients (44, 45) . In our study, the ROC01 curve analysis of the PA and PS group 348 qRT-PCR data showed that all shortlisted S100s (except S100A12) had significant 349 sensitivity as a prognostic marker of symptomatic COVID-19 (Figure 4 C, D) . Overall, 350 taking our data and published information together, the S100 family of genes can be (56), which is required for SARS-CoV-2 viral protein translation (57, 58). This 389 may also contribute to its mechanism of action, however, that needs to be further shows the optimal Ct cut-off determined by the ROC01 method (also shown in the 511 label in each graph). D) Optimal Ct cut-off, sensitivity, and specificity values for 512 significant S100 family of genes. infected animals and viral RNA copy number was measured by qRT-PCR. Log10 copy 531 number of vRNA per µg total RNA is plotted on the graph (n=4). F) Body weight of 532 hamsters was measured from D0 to D4 and plotted on the graph, considering weight 533 on D0 as 100% (n=4). Error bars represent mean + standard error. Differences 534 between test groups and control group were computed using the t-test with Bonferroni 535 corrections for multiple comparisons. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 536 0.0001; ns -not significant. propagated and titered by plaque assay in Vero E6 cells as described before (61). 

The retrieved datasets were then filtered by their date of publication to collect the 601 studies published between the 1 st of January 2020 and the 15 th of September 2020.

The filtration of datasets was carried out using two parameters, fold-change, and its Optimal cut-off determination were performed using the online tool easyROC (ver. 

Coronaviridae Study Group of the International Committee on Taxonomy of V. The species 715 Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-716

COVID-19 and the immune system

Antiviral actions of interferons

SARS and MERS: recent insights into 722 emerging coronaviruses

The damage-response framework of microbial pathogenesis

In vivo antiviral host 726 transcriptional response to SARS-CoV-2 by viral load, sex, and age

728 Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

Transcriptomic characteristics of 730 bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Heightened Innate Immune Responses in 733 the Respiratory Tract of COVID-19 Patients

Quantitative proteomic 735 dataset from oro-and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins 736 and host's biological processes altered by the infection

Proteins associated 738 with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients. 739 PLoS One

Multi-Omics integration analysis of 741 respiratory specimen characterizes baseline molecular determinants associated with

A SARS-CoV-2 protein 744 interaction map reveals targets for drug repurposing

Higher viral loads 746 in asymptomatic COVID-19 patients might be the invisible part of the iceberg

Asymptomatic and Symptomatic Patients With Non-749 severe Coronavirus Disease (COVID-19) Have Similar Clinical Features and Virological Courses: A 750 Retrospective Single Center Study

genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim 753 Biophys Acta Mol Basis Dis

Enhancement of auranofin-induced lung cancer 755 cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo

The FDA-approved gold drug 758 auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human 759 cells

COVID-19: A review of therapeutic strategies and vaccine 761 candidates

Drug repurposing approach 763 to fight COVID-19

Host cell factors in 765 HIV replication: meta-analysis of genome-wide studies

Interferome v2.0: an 767 updated database of annotated interferon-regulated genes

Interferon-stimulated genes: a complex web of host 770 defenses

Functions of S100 proteins

S100 Proteins As an Important Regulator of 777

easyROC: An Interactive Web-tool for 779 ROC Curve Analysis Using R Language Environment

Potential role of 783 thioredoxin in immune responses in intestinal lamina propria T lymphocytes

Syrian 786 hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

American Society of Health-System 789 Pharmacists

Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding

Selective regulation in ribosome biogenesis and protein 794 production for efficient viral translation

Ribosomal protein S5 796 interacts with the internal ribosomal entry site of hepatitis C virus

SARS-CoV-2 Nsp1 799 binds the ribosomal mRNA channel to inhibit translation

The Differential Expression of Mitochondrial Function-801

Associated Proteins and Antioxidant Enzymes during Bovine Herpesvirus 1 Infection: A Potential 802 Mechanism for Virus Infection-Induced Oxidative Mitochondrial Dysfunction

Human herpesvirus 1 protein 805 US3 induces an inhibition of mitochondrial electron transport

Age-807 specific mortality and immunity patterns of SARS-CoV-2

Mild versus severe COVID-19: Laboratory markers

Factors associated with death outcome in patients 811 with severe coronavirus disease-19 (COVID-19): a case-control study

Cross-class inhibition 814 of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a 815 kinetic analysis

Critical role of 819 serpinB1 in regulating inflammatory responses in pulmonary influenza infection

Characterization of the Inflammatory Response to Severe COVID-19 Illness

alpha1-Antitrypsin deficiency and the risk of COVID-19: 825 an urgent call to action

An integrative analysis identifying 827 transcriptional features and key genes involved in COVID-19

Proteomic characteristics of 829 bronchoalveolar lavage fluid in critical COVID-19 patients

Characterization of spike glycoprotein of SARS-CoV-2 831 on virus entry and its immune cross-reactivity with SARS-CoV

835 52. van Dam L, Dansen TB. Cross-talk between redox signalling and protein aggregation

Inhibition of thioredoxin 838 reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells

Auranofin: repurposing an old drug for a golden new age

Auranofin, an immunosuppressive drug, 843 inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells

Auranofin-mediated inhibition of 846 PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

mTOR 849 inhibition in COVID-19: A commentary and review of efficacy in RNA viruses

An Open Question: 852 Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?

Test and visualize gene overlaps

Metascape 857 provides a biologist-oriented resource for the analysis of systems-level datasets

Growth, detection, quantification, and 860 inactivation of SARS-CoV-2

The 862 PRIDE database and related tools and resources in 2019: improving support for quantification data

NCBI GEO: archive 865 for functional genomics data sets--update

A comprehensive 867 protein-centric ID mapping service for molecular data integration

Elegant Graphics for Data Analysis

UniProt: a worldwide hub of protein knowledge

A subcellular map of 872 the human proteome

Tissue-based map of the human proteome

Cytoscape: a software 876 environment for integrated models of biomolecular interaction networks

Complex heatmaps reveal patterns and correlations in 879 multidimensional genomic data